Log in to search using one of your social media accounts:

 

Should coffee come with a cancer warning?
Coffee shops are being sued under California's Proposition 65 which requires businesses to alert consumers about cancer-causing chemicals (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 8, 2018 Category: Consumer Health News Source Type: news

Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio
(Source: Johnson and Johnson)
Source: Johnson and Johnson - February 8, 2018 Category: Pharmaceuticals Source Type: news

Pillsbury Plant Owner Sentenced for Asbestos Violations
Federal judge Sue Myerscough sentenced a part owner of the shuttered Pillsbury Mills complex in Springfield, Illinois, Monday to three years in prison for violating clear air standards with the illegal removal of asbestos products. Joseph Chernis IV pleaded guilty to illegal removal, demolition and disposal of asbestos after using untrained workers to remove dry pipe insulation and store it in open containers, trash bags and cardboard boxes. He is still facing an ongoing civil case brought by the Illinois Environmental Protection Agency (EPA). “I have grave concerns about the damage to the community in this case,&rd...
Source: Asbestos and Mesothelioma News - February 8, 2018 Category: Environmental Health Authors: Matt Mauney Tags: asbestos exposure asbestos regulations asbestos violations asbestosis clear air standards flour-milling plant Springfield Illinois Environmental Protection Agency Joseph Chernis IV judge Sue Myerscough lung cancer mesothelioma Pillsb Source Type: news

Patient Advocate Says Novartis' $475,000 Breakthrough Should Cost Just $160,000
David Mitchell, 67, says he ’s sure that Novartis’ Kymriah is a breakthrough medicine, and that he will need a similar medicine to treat his own blood cancer. He’s sure of something else, too: Novartis is charging too much. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 8, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:NVS NASDAQ:CELG NASDAQ:GILD NASDAQ:JUNO Source Type: news

Cell phone radiation exposure found to give rats CANCER
(Natural News) A new study released by the National Institutes of Health shows that exposure to cell phone radiation known as RFR causes male rats to develop a rare type of cancer. According to two technical reports on mice and rats, the RFR exposure caused male rats to develop tumors in the tissues that surround... (Source: NaturalNews.com)
Source: NaturalNews.com - February 8, 2018 Category: Consumer Health News Source Type: news

Concerns over cancer-causing chemical in coffee overblown?
A cup of coffee in California could soon come with a cancer warning. The Council for Education and Research on Toxins wants businesses to warn consumers about a possible cancer risk from coffee. The push for a warning stems from a natural chemical produced when coffee beans are roasted. John Blackstone reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 8, 2018 Category: Consumer Health News Source Type: news

Morning Break: New HIV Drug Combo; Asparagus-Cancer Link; Celeb-Suicide Effect?
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 8, 2018 Category: Primary Care Source Type: news

Is Federal Policy Really To Blame For The High Cost Of Cancer Care?
Although cancer care is increasingly becoming hospital or health system based, merger mania in oncology is probably not driven primarily as a way for hospitals to gain access to discounted drugs. Broader forces are at play. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 8, 2018 Category: Pharmaceuticals Authors: Peter Ubel, Contributor Source Type: news

Who's To Blame For The High Cost Of Cancer Care (The Federal Government Or Justin Bieber?)
Although cancer care is increasingly becoming hospital or health system based, merger mania in oncology is probably not driven primarily as a way for hospitals to gain access to discounted drugs. Broader forces are at play. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 8, 2018 Category: Pharmaceuticals Authors: Peter Ubel, Contributor Source Type: news

More Than Half of UK Docs Support Assisted Dying More Than Half of UK Docs Support Assisted Dying
The British Medical Association has long been opposed to assisted dying, but a recent poll found that 55% of physicians would support its becoming legal in defined circumstances.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 8, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Waiting to Treat the Cancer
It would be a race between the leukemia returning and the insurance company approving the procedure that could keep it at bay permanently. (Source: NYT Health)
Source: NYT Health - February 8, 2018 Category: Consumer Health News Authors: MIKKAEL A. SEKERES, M.D. Tags: Leukemia Transplants Bone Marrow Health Insurance and Managed Care Chemotherapy Testicles Cancer Source Type: news

Zimbabwe:First Lady Screened for Cervical, Breast Cancer
[The Herald] Firsty Lady Auxillia Mnangagwa was yesterday screened for cervical and breast cancer at United Bulawayo Hospitals (UBH) as a way of motivating women to do the same as the country intensifies the fight against the silent killer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 8, 2018 Category: African Health Source Type: news

Zimbabwe:UK-Based Cancer Survivor Launches Anka Beauty Range
[New Zimbabwe] A United Kingdom (UK) based Zimbabwean breast cancer survivor, Prisca Chireka, launched her beauty product in the country this Wednesday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 8, 2018 Category: African Health Source Type: news

UCSF receives another record $500M donation from Helen Diller Foundation to build new hospital
UCSF has received a $500 million commitment from the Helen Diller Foundation toward rebuilding its Parnassus Heights hospital in the Inner Sunset District. This is the foundation’s third major contribution to the University of California, San Francisco in the last 15 years. In total, the family foundation has donated or committed more than $1.15 billion to the university to support faculty and students, innovation programs and cancer research. The gift will allow UCSF to begin the planning… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 8, 2018 Category: American Health Authors: Antoinette Siu Source Type: news

Medical News Today: Asparagus amino acid helps deadly breast cancer to spread
An amino acid derived from a wide range of foods, including asparagus, helps triple-negative breast cancer to spread in the body, a new study has found. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 8, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Tanzania:Cancer Alarm As Number of New Cases Skyrockets
[Daily News] Moshi -THERE is an alarming upward trend in the number of people diagnosed with cancer, as a Northern Zone referral hospital attended to 3,450 patients against the target of 600 patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 8, 2018 Category: African Health Source Type: news

Cancer-Causing HPV Can Hide in the Throat
Title: Cancer-Causing HPV Can Hide in the ThroatCategory: Health NewsCreated: 2/7/2018 12:00:00 AMLast Editorial Review: 2/8/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 8, 2018 Category: Cancer & Oncology Source Type: news

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. (Source: HSR Information Central)
Source: HSR Information Central - February 8, 2018 Category: International Medicine & Public Health Source Type: news

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. (Source: HSR Information Central)
Source: HSR Information Central - February 8, 2018 Category: International Medicine & Public Health Source Type: news

Nigeria:Nigeria's Death Rate From Cancer to Rise to 75% By 2030, Says WHO
[This Day] Abuja -?Nigeria is predicted to expect a 75 per cent increase in cancer-induced death come the year 2030, as it happens to be a member of the Low-Medium Income Countries which statistics has revealed will suffer from the effects of the virus. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 8, 2018 Category: African Health Source Type: news

Depth of Response in PETHEMA/GEM Myeloma Trials Depth of Response in PETHEMA/GEM Myeloma Trials
According to this research, minimal residual disease negativity should be considered one of the most relevant clinical endpoints for some populations of patients with MM.Journal of Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Depth of Response in NSCLC with Targeted or Immunotherapies Depth of Response in NSCLC with Targeted or Immunotherapies
Greater depth of response may be associated with overall survival and progression-free survival and could be considered as an additional outcome measure for clinical trials.Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Stem cell research provides hope for tasmanian devils with a deadly, transmissible cancer
(Morris Animal Foundation) Using stem cell therapy, Morris Animal Foundation-funded researcher Dr. Deanne Whitworth and her colleagues at the University of Queensland, have taken the first step toward developing an effective treatment for devil facial tumor disease (DFTD), which is decimating Tasmanian devils in the wild. The team's findings were recently published in Stem Cells and Development. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 8, 2018 Category: Biology Source Type: news

Apalutamide delays progression of nonmetastatic, castration-resistant prostate cancer
(Massachusetts General Hospital) A multi-institutional phase 3 trial led by investigators at Massachusetts General Hospital and University of California, San Francisco found that treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2018 Category: Cancer & Oncology Source Type: news

New tool helps physicians estimate survival for patients with cancers that have spread to bone
(Wolters Kluwer Health) A simple three-factor tool can help doctors estimate survival time in patients with long bone metastases (LBMs) -- advanced cancer that has spread to the bones of the limbs, reports a study in the February 7, 2018, issue of The Journal of Bone& Joint Surgery. The journal is published in partnership with Wolters Kluwer. Reliable survival estimates in these cases can help prevent overtreatment and undertreatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2018 Category: Cancer & Oncology Source Type: news

TSRI scientists take big step toward stopping cancer metastasis
(Scripps Research Institute) TSRI scientists identify molecule that fuels cancer metastasis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2018 Category: Cancer & Oncology Source Type: news

Molecular 'magnets' could improve cancer immunotherapy
(The Francis Crick Institute) Chemicals that attract specialised immune cells toward tumours could be used to develop better immunotherapies for cancer patients, according to new research published in Cell.Scientists at the Francis Crick Institute have discovered that immune cells called Natural Killer cells accumulate in tumours and release chemicals that attract specialised dendritic cells (cDC1) - white blood cells known for triggering anti-cancer immune responses - to the tumour. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2018 Category: Cancer & Oncology Source Type: news

University of Missouri Research Reactor supplying radioisotope for new cancer drug
(University of Missouri-Columbia) Scientists at the University of Missouri's Research Reactor (MURR) identified promising properties of the radioisotope lutetium-177 (Lu-177), which can be used to treat cancer. Recently the U.S. FDA approved a Lu-177 based drug, Lutathera ® (lutetium Lu-177 dotatate), to treat certain types of tumors that can occur in the gastrointestinal tract and pancreas. MURR is the sole US supplier of Lu-177 for use in Lutathera ® , which was developed by Advanced Accelerator Applications. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2018 Category: Cancer & Oncology Source Type: news

Undergraduate student uncovers genes associated with aggressive form of brain cancer
(Clemson University) Using publicly available data and novel computer software called KINC, an undergraduate researcher in genetics and biochemistry at Clemson University was able to uncover a group of 22 genes that are implicated together as having involvement in glioblastoma, the most aggressive type of brain cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2018 Category: Cancer & Oncology Source Type: news

Black patients more likely to be excluded from prostate cancer trials
(Brigham and Women's Hospital) Study finds nearly half of all prostate cancer randomized clinical trials use lab results that are more likely to exclude black patients due to racial variations in laboratory values. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 8, 2018 Category: International Medicine & Public Health Source Type: news

Genetic gene mutations: Opening new therapeutic avenues in metastatic prostate cancer
(Vall d'Hebron Institute of Oncology) International study shows the prognostic and predictive value of DNA-repair gene mutations in more precisely selecting standard therapies for the treatment of metastatic prostate cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 8, 2018 Category: International Medicine & Public Health Source Type: news

Teleconsulting to bring specialised expertise in rare cancers across Europe
(European Society for Medical Oncology) How collaborative networks are giving patients with rare cancers a chance at better outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 8, 2018 Category: International Medicine & Public Health Source Type: news

Researchers develop breakthrough technique to combat cancer drug resistance
(University of Maryland) The ability for cancer cells to develop resistance to chemotherapy drugs -- known as multi-drug resistance -- remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to 'turn off' their resistance capabilities. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 8, 2018 Category: International Medicine & Public Health Source Type: news

Researchers uncover how cancer stem cells drive triple-negative breast cancer
(Cleveland Clinic) Cleveland Clinic researchers have published findings in Nature Communications on a new stem cell pathway that allows a highly aggressive form of breast cancer -- triple-negative breast cancer -- to thrive. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2018 Category: Cancer & Oncology Source Type: news

Harnessing the power of genomic sequencing augments diagnosis and treatment of lymphoid cancer
(Elsevier) A new study published in The Journal of Molecular Diagnostics has established that hybrid-capture sequencing is the method of choice for sequencing 'actionable' gene mutations across the most common forms of lymphoid cancer. Due to its applicability in routinely acquired formalin-fixed, paraffin-embedded tissues, this assay can be implemented by clinical laboratories into routine diagnostic workflows. It reliably identifies potentially actionable gene mutations in 91 percent of patients, bringing the benefits of precision diagnosis and individualized therapy to patients with lymphoid cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 8, 2018 Category: Biology Source Type: news

Gene Assay Informs Chemo Decision in Breast Cancer (CME/CE)
(MedPage Today) -- 10-year recurrence risk of 3.5% in low-risk, node-positive disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 8, 2018 Category: Hematology Source Type: news

Precision drug for prostate may help 3,000 cancer patients
British scientists are leading a global trial of a daily pill that uses a man's genetic make-up to undermine a tumour's defences. (Source: the Mail online | Health)
Source: the Mail online | Health - February 8, 2018 Category: Consumer Health News Source Type: news

Programming gene and engineered-cell therapies with synthetic biology
Gene and engineered-cell therapies promise to treat diseases by genetically modifying cells to carry out therapeutic tasks. Although the field has had some success in treating monogenic disorders and hematological malignancies, current approaches are limited to overexpression of one or a few transgenes, constraining the diseases that can be treated with this approach and leading to potential concerns over safety and efficacy. Synthetic gene networks can regulate the dosage, timing, and localization of gene expression and therapeutic activity in response to small molecules and disease biomarkers. Such "programmable&quo...
Source: ScienceNOW - February 8, 2018 Category: Science Authors: Kitada, T., DiAndreth, B., Teague, B., Weiss, R. Tags: Molecular Biology, Online Only review Source Type: news

Pancreatic cancer patients should be offered early scans to avoid unnecessary surgery, says NICE
NICE recommends the use of a more accurate scan to diagnose and determine the stage of pancreatic cancer in patients. (Source: NHS Networks)
Source: NHS Networks - February 8, 2018 Category: UK Health Source Type: news

Cancer-Causing HPV Can Hide in the Throat
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 8, 2018 Category: Cancer & Oncology Source Type: news

Prophylactic oophorectomy: Preventing cancer by surgically removing your ovaries
Find out what to consider and what to ask your doctor when deciding whether to undergo surgery to prevent ovarian and breast cancers. (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - February 8, 2018 Category: Consumer Health News Source Type: news

HPV vaccine has stalled cancers in Finland report claims
All the Finnish women who got the first HPV vaccine in 15 years ago are cancer-free. The report is a huge endorsement for the shot, suggesting it works at preventing HPV-related disease. (Source: the Mail online | Health)
Source: the Mail online | Health - February 7, 2018 Category: Consumer Health News Source Type: news

Many breast cancer survivors may die of heart disease, doctors warn
(Reuters Health) - The same advances in breast cancer treatment that have dramatically improved survival in recent years have also left a growing number of women vulnerable to potentially fatal cardiovascular problems, the American Heart Association warns. (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Cancer-Causing HPV Can Hide in the Throat
Testing can detect HPV before it leads to cervical cancer. However, that's not the case for head and neck cancers, the researchers said. (Source: WebMD Health)
Source: WebMD Health - February 7, 2018 Category: Consumer Health News Source Type: news

Varian Halcyon Treatment System Receives AERB Certificate for Import & amp; Supply in India
PALO ALTO, Calif. and MUMBAI, India - Feb. 6, 2018 - Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India. This registration allows Varian to now market this new system in India. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), and is well suited to treat a majority of cancer patients, offering...This story is related to the following:Clinical Medical Equipment (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - February 7, 2018 Category: Medical Devices Source Type: news

Maryland Governor shows off scars after cancer surgery
Maryland Gov. Larry Hogan is showing off his battle scars in what he says is his second successful fight against cancer (Source: ABC News: Health)
Source: ABC News: Health - February 7, 2018 Category: Consumer Health News Tags: Health Source Type: news

Why You Should Wear Sunscreen on Every Flight
This article originally appeared on TravelandLeisure.com (Source: TIME: Health)
Source: TIME: Health - February 7, 2018 Category: Consumer Health News Authors: Claudia Fisher / Travel + Leisure Tags: Uncategorized onetime onetimetravel Source Type: news

60-Year-Old Drug May Hold Clues To Stopping Spread Of Breast Cancer
One of the oldest chemotherapy drugs in the world may be able to stop breast cancer spreading, according to a new study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 7, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

This is why you should never ignore a cough that won’t go away
CANCER symptoms can vary depending on where in the body the tumour is. But, if you have a cough that won ’t go away, you should see a GP. (Source: Daily Express - Health)
Source: Daily Express - Health - February 7, 2018 Category: Consumer Health News Source Type: news

Spread of breast cancer linked to compound in asparagus and other foods
Using drugs or diet to reduce levels of asparagine may benefit patients, say researchersBreast cancer patients could be encouraged to cut asparagus and other foods from their diets in the future to reduce the risk of the disease spreading, scientists say.Researchers are investigating whether a change in diet could help patients with breast tumours after studies in mice showed that asparagine, a compound first identified in asparagus but present in many other foods, drives the spread of the disease to other organs.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 7, 2018 Category: Science Authors: Ian Sample Science editor Tags: Cancer research Science UK news Health Medical research Society Source Type: news